triglide Drug Patent Profile
✉ Email this page to a colleague
When do Triglide patents expire, and when can generic versions of Triglide launch?
Triglide is a drug marketed by Skyepharma Ag and is included in one NDA.
The generic ingredient in TRIGLIDE is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triglide
A generic version of triglide was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for triglide?
- What are the global sales for triglide?
- What is Average Wholesale Price for triglide?
Summary for triglide
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Clinical Trials: | 2 |
Patent Applications: | 3,604 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for triglide |
DailyMed Link: | triglide at DailyMed |
Recent Clinical Trials for triglide
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Medical University of South Carolina | Phase 4 |
National Institutes of Health (NIH) | N/A |
National Heart, Lung, and Blood Institute (NHLBI) | N/A |
US Patents and Regulatory Information for triglide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-001 | May 7, 2005 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-002 | May 7, 2005 | BX | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for triglide
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-001 | May 7, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Skyepharma Ag | TRIGLIDE | fenofibrate | TABLET;ORAL | 021350-002 | May 7, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for triglide
See the table below for patents covering triglide around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Spain | 2372746 | ⤷ Sign Up | |
Austria | 367802 | ⤷ Sign Up | |
Hong Kong | 1061357 | ⤷ Sign Up | |
Canada | 2423336 | MICROPARTICULES DE FIBRATE STABILISEES (STABILISED FIBRATE MICROPARTICLES) | ⤷ Sign Up |
Canada | 2484375 | FORMES DOSIFIEES ORALES CONTENANT DU FENOFIBRATE (ORAL DOSAGE FORMS COMPRISING FENOFIBRATE) | ⤷ Sign Up |
Taiwan | I293877 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |